# Novartis Gene Therapies, Inc. – FDA Inspection, Jun 16, 2021

Source: https://www.keypedia.com/records/fda_inspections/novartis-gene-therapies-inc/13259416-d963-4c3e-9e31-3b3d50b8daf5
Source feed: FDA_Inspections

> FDA inspection 1144535 of Novartis Gene Therapies, Inc., June 16, 2021. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR parts 211 and 212. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1144535
- Company Name: Novartis Gene Therapies, Inc.
- Inspection Date: 2021-06-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 5

## Related Documents

- [FDA Inspection 1086650 - 2019-02-08](https://www.keypedia.com/records/fda_inspections/novartis-gene-therapies-inc/b459a2fc-1008-4989-8b52-22767733d792)

Company: https://www.keypedia.com/companies/novartis-gene-therapies-inc/58c140f1-7389-4053-a757-b61650a3a86a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d